CompuGroup Medical SE & Co. KGaA

DB:COP Stock Report

Market Cap: €1.2b

CompuGroup Medical SE KGaA Valuation

Is COP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of COP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
€32.78
Fair Value
30.3% undervalued intrinsic discount
9
Number of Analysts

Below Fair Value: COP (€22.84) is trading below our estimate of fair value (€32.78)

Significantly Below Fair Value: COP is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for COP?

Key metric: As COP is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for COP. This is calculated by dividing COP's market cap by their current earnings.
What is COP's PE Ratio?
PE Ratio48.7x
Earnings€25.17m
Market Cap€1.23b

Price to Earnings Ratio vs Peers

How does COP's PE Ratio compare to its peers?

The above table shows the PE ratio for COP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average23.3x
NXU Nexus
44.4x16.9%€1.2b
M3V MeVis Medical Solutions
10.1xn/a€46.2m
AJ91 DocCheck
17.7xn/a€43.4m
RHK RHÖN-KLINIKUM
21x7.5%€943.8m
COP CompuGroup Medical SE KGaA
48.7x30.1%€1.2b

Price-To-Earnings vs Peers: COP is expensive based on its Price-To-Earnings Ratio (48.7x) compared to the peer average (23.3x).

Price to Earnings Ratio vs Industry

How does COP's PE Ratio compare vs other companies in the European Healthcare Services Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
COP 48.7xIndustry Avg. 38.1xNo. of Companies3PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: COP is expensive based on its Price-To-Earnings Ratio (48.7x) compared to the Global Healthcare Services industry average (34.7x).

Price to Earnings Ratio vs Fair Ratio

What is COP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

COP PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio48.7x
Fair PE Ratio44.6x

Price-To-Earnings vs Fair Ratio: COP is expensive based on its Price-To-Earnings Ratio (48.7x) compared to the estimated Fair Price-To-Earnings Ratio (44.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst COP forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€22.84
€21.28
-6.8%
22.7%€29.00€10.00n/a9
Jan ’26€21.70
€21.00
-3.2%
26.8%€29.00€10.00n/a10
Dec ’25€15.86
€21.75
+37.1%
25.6%€31.00€16.00n/a10
Nov ’25€13.81
€26.85
+94.4%
50.2%€64.00€16.00n/a10
Oct ’25€14.15
€27.25
+92.6%
48.5%€64.00€16.00n/a10
Sep ’25€15.55
€29.95
+92.6%
53.3%€64.00€16.00n/a10
Aug ’25€15.93
€29.95
+88.0%
53.3%€64.00€16.00n/a10
Jul ’25€23.74
€42.80
+80.3%
29.5%€64.00€31.00n/a10
Jun ’25€27.22
€43.20
+58.7%
30.4%€64.00€31.00n/a10
May ’25€28.28
€46.05
+62.8%
25.8%€65.00€32.50n/a10
Apr ’25€28.36
€48.45
+70.8%
22.1%€65.00€36.00n/a10
Mar ’25€29.12
€48.45
+66.4%
22.1%€65.00€36.00n/a10
Feb ’25€39.90
€54.05
+35.5%
22.1%€76.00€39.00€23.0410
Jan ’25€37.86
€55.50
+46.6%
20.7%€76.00€41.00€21.7010
Dec ’24€35.16
€54.91
+56.2%
17.9%€70.00€41.00€15.8611
Nov ’24€34.60
€55.91
+61.6%
16.2%€70.00€41.00€13.8111
Oct ’24€37.20
€55.91
+50.3%
16.2%€70.00€41.00€14.1511
Sep ’24€43.20
€56.82
+31.5%
15.1%€70.00€41.00€15.5511
Aug ’24€46.02
€57.82
+25.6%
13.4%€70.00€41.00€15.9311
Jul ’24€45.18
€57.82
+28.0%
13.4%€70.00€41.00€23.7411
Jun ’24€49.84
€57.41
+15.2%
15.1%€70.00€36.50€27.2211
May ’24€49.28
€57.41
+16.5%
15.1%€70.00€36.50€28.2811
Apr ’24€46.68
€58.14
+24.5%
15.8%€70.00€36.50€28.3611
Mar ’24€45.24
€58.05
+28.3%
16.0%€70.00€36.50€29.1211
Feb ’24€43.94
€57.55
+31.0%
19.1%€68.00€36.50€39.9011
Analyst Price Target
Consensus Narrative from 9 Analysts
€21.30
Fair Value
7.2% overvalued intrinsic discount
9
Number of Analysts

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 01:59
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CompuGroup Medical SE & Co. KGaA is covered by 17 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Knut WollerBaader Helvea Equity Research
Gerhard SchwarzBaader Helvea Equity Research
Gunnar CohrsBerenberg